Takeshi Takahashi
Director/Miembro de la Junta en Pathalys Pharma, Inc. .
Cargos activos de Takeshi Takahashi
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Director/Miembro de la Junta | - | - |
Historial de carrera de Takeshi Takahashi
Antiguos cargos conocidos de Takeshi Takahashi.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/05/2020 | 12/09/2023 |
| Independent Dir/Board Member | 01/05/2020 | 12/09/2023 | |
| TSUGAMI CORPORATION | Director de Operaciones | 01/04/2020 | - |
| Director Técnico/Científico/I+D | 01/04/2020 | - | |
| Corporate Officer/Principal | - | 01/04/2020 |
Formación de Takeshi Takahashi.
| Waseda University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Japón | 3 |
Operativa
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| TSUGAMI CORPORATION | Producer Manufacturing |
| Empresas privadas | 1 |
|---|---|
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Health Technology |
- Bolsa de valores
- Insiders
- Takeshi Takahashi
- Experiencia
